Literature DB >> 33330780

Guidelines for the diagnosis and treatment of coronavirus disease 2019 (COVID-19) in China.

Youyao Xu1, Yizhen Chen1, Xiaoyan Tang2.   

Abstract

With the deepening of the understanding and research in coronavirus disease 2019 (COVID-19), the diagnosis and treatment of COVID-19 have been constantly updated and improved. In China, since the implementation of "Guidelines for the Diagnosis and Treatment of COVID-19 (1st Trial Version)" on Jan. 15, 2020, 2nd to 7th versions (including revision of 5th version) was updated from Jan. 18, Jan. 22, Jan. 27, Feb. 4, Feb. 8, Feb. 18 and Mar. 3, respectively. Versions updated subsequently provide more detailed information in many ways than the 1st and 2nd versions, so this paper will introduce the development of the main contents of the 3rd to 7th versions of COVID-19 guidelines in China, which hopes to provide help for clinical medical staff in other countries fighting with this disease. 2020, National Center for Global Health and Medicine.

Entities:  

Keywords:  COVID-19; diagnosis and treatment; guideline

Year:  2020        PMID： 33330780      PMCID： PMC7731342          DOI： 10.35772/ghm.2020.01015

Source DB:  PubMed          Journal:  Glob Health Med        ISSN： 2434-9186


  3 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

3.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245
  3 in total
  17 in total

1.  The selection of indicators from initial blood routine test results to improve the accuracy of early prediction of COVID-19 severity.

Authors:  Jiaqing Luo; Lingyun Zhou; Yunyu Feng; Bo Li; Shujin Guo
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

2.  Decreased T Cell Levels in Critically Ill Coronavirus Patients: Single-Center, Prospective and Observational Study.

Authors:  Jingjing Xu; Zhiyu Liu; Haitao Liu; Yunpeng Luo; Kai Kang; Xueting Li; Wei Yang; Dongsheng Fei; Changsong Wang; Kaijiang Yu
Journal:  J Inflamm Res       Date:  2021-04-09

3.  Predictive factors of erectile dysfunction in Egyptian individuals after contracting COVID-19: A prospective case-control study.

Authors:  Hany Mohammed Saad; Sameh Fayek GamalEl Din; Osama Mohamed Elbokl; Ahmed Adel
Journal:  Andrologia       Date:  2021-11-13       Impact factor: 2.532

Review 4.  Impact of the COVID-19 pandemic on food production and animal health.

Authors:  Parastoo Rahimi; Md Saiful Islam; Phelipe Magalhães Duarte; Sina Salajegheh Tazerji; Md Abdus Sobur; Mohamed E El Zowalaty; Hossam M Ashour; Md Tanvir Rahman
Journal:  Trends Food Sci Technol       Date:  2021-12-06       Impact factor: 12.563

5.  Listening to COVID-19 survivors: what they need after early discharge from hospital - a qualitative study.

Authors:  Min Guo; Min Kong; Wenxin Shi; Man Wang; Haixia Yang
Journal:  Int J Qual Stud Health Well-being       Date:  2022-12

6.  Discovery of potential imaging and therapeutic targets for severe inflammation in COVID-19 patients.

Authors:  Hyung-Jun Im; Kwon Joong Na; Hongyoon Choi; Hyunjong Lee; Jeongbin Park
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

7.  The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction.

Authors:  Suowen Xu; Yujie Liu; Yu Ding; Sihui Luo; Xueying Zheng; Xiumei Wu; Zhenghong Liu; Iqra Ilyas; Suyu Chen; Shuxin Han; Peter J Little; Mukesh K Jain; Jianping Weng
Journal:  Signal Transduct Target Ther       Date:  2021-07-12

Review 8.  Epidemiology, clinical spectrum, viral kinetics and impact of COVID-19 in the Asia-Pacific region.

Authors:  Kin On Kwok; Ying Huang; Margaret Ting Fong Tsoi; Arthur Tang; Samuel Yeung Shan Wong; Wan In Wei; David Shu Cheong Hui
Journal:  Respirology       Date:  2021-03-09       Impact factor: 6.424

9.  Impaired semen parameters in patients with confirmed SARS-CoV-2 infection: A prospective cohort study.

Authors:  Yasar Pazir; Tolga Eroglu; Ayse Kose; Taha Burak Bulut; Cihat Genc; Mustafa Kadihasanoglu
Journal:  Andrologia       Date:  2021-07-15       Impact factor: 2.532

Review 10.  Developments in pediatrics in 2020: choices in allergy, autoinflammatory disorders, critical care, endocrinology, genetics, infectious diseases, microbiota, neonatology, neurology, nutrition, ortopedics, respiratory tract illnesses and rheumatology.

Authors:  Carlo Caffarelli; Francesca Santamaria; Michela Procaccianti; Ettore Piro; Valeria Delle Cave; Melissa Borrelli; Angelica Santoro; Federica Grassi; Sergio Bernasconi; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2021-12-07       Impact factor: 2.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.